Argent BioPharma Limited
RGTLF
$0.0599
$0.011423.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.96M | -4.07M | -3.44M | -3.44M | -2.31M |
| Total Depreciation and Amortization | 202.40K | 208.10K | 210.60K | 210.10K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.37M | 2.43M | 1.46M | 1.46M | -270.20K |
| Change in Net Operating Assets | -- | -- | -456.90K | -456.00K | -- |
| Cash from Operations | -1.39M | -1.43M | -2.23M | -2.22M | -2.58M |
| Capital Expenditure | -700.00 | -800.00 | -40.60K | -40.50K | -5.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -700.00 | -800.00 | -40.60K | -40.50K | -5.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -67.70K | -67.70K | -58.90K | -58.90K | -60.40K |
| Issuance of Common Stock | 2.31M | 2.31M | 533.10K | 533.10K | 7.44M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -94.50K | -94.50K | 79.10K | 79.10K | -297.30K |
| Cash from Financing | 1.40M | 1.44M | 364.60K | 363.90K | 4.61M |
| Foreign Exchange rate Adjustments | -2.30K | -2.30K | -1.90K | -1.90K | 1.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.10K | 5.20K | -1.90M | -1.90M | 2.03M |